MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11033-025-10431-4

Медицинская библиотека · Molecular biology reports · 2025

High de novo mutation rate in Iranian NF2-related schwannomatosis patients with a report of a novel NF2 mutation.

Ghalavand Mohammad Amin, Asghari Alimohamad, Jahanbakhshi Amin, Falavarjani Khalil Ghasemi, Eftekharian Ali, Farhadi Mohammad, Emamdjomeh Hessamaldin, Garshasbi Masoud, Falah Masoumeh

СтатьяПеревод в очереди

Аннотация

BACKGROUND

NF2-related schwannomatosis (NF2) is a rare genetic disease that significantly impacts patients' quality of life due to the occurrence of multiple tumors within the nervous system. The high clinical heterogeneity in tumor number, location, and size makes predicting each patient's clinical outcome impossible. Genetic investigation can be crucial in diagnosis, prognosis, and management. This study aims to explore the genetic basis of eight Iranian patients with NF2.

METHODS AND

RESULTS

To investigate potential genetic causes, we conducted comprehensive medical evaluations, whole-exome sequencing (WES), and multiplex ligation-dependent probe amplification (MLPA) on the probands of each family. The identified variants in the family members were confirmed using Sanger sequencing and MLPA. The variants were classified according to the American College of Medical Genetics and Genomics guidelines. Seven distinct variants linked to the NF2 gene were identified as causes of NF2-related schwannomatosis in these patients, among which the c.862_863del frameshift was a novel variant not previously reported. Seventy-five percent of these mutations were de novo. The mean diagnostic age was lower among patients with truncating mutations compared to other patients.

CONCLUSIONS

This study identified a novel mutation in the NF2 gene and showed a high rate of de novo mutations in Iranian NF2 patients. Moreover, patients with truncating mutations experienced earlier symptoms than others. Comparing the manifestations of each patient with similar mutations to previous reports expands our understanding of the phenotype of NF2. These results can provide more comprehensive insights into prognosis and early interventions.

Для цитирования: Ghalavand Mohammad Amin, Asghari Alimohamad, Jahanbakhshi Amin, Falavarjani Khalil Ghasemi, Eftekharian Ali, Farhadi Mohammad, Emamdjomeh Hessamaldin, Garshasbi Masoud, Falah Masoumeh. High de novo mutation rate in Iranian NF2-related schwannomatosis patients with a report of a novel NF2 mutation.. Molecular biology reports. 2025. DOI: 10.1007/s11033-025-10431-4.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.